CRP and hypogonadism: Saad et al. investigated the effects of TU injection in 110 elderly men with obesity and MS and demonstrated that age, BMI, and C-reactive protein (CRP) levels, in addition to hypogonadism, can be used clinically to predict which men mostly benefit from T supplementation with regard to components of the MS [20].